Search Results - "B. Julg"

Refine Results
  1. 1

    Enhanced Anti-HIV Functional Activity Associated with Gag-Specific CD8 T-Cell Responses by Julg, B, Williams, K L, Reddy, S, Bishop, K, Qi, Y, Carrington, M, Goulder, P J, Ndung'u, T, Walker, B D

    Published in Journal of Virology (01-06-2010)
    “…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article
  2. 2

    Infrequent Recovery of HIV from but Robust Exogenous Infection of Activated CD4+ T Cells in HIV Elite Controllers by Julg, B., Pereyra, F., Buzón, M. J., Piechocka-Trocha, A., Clark, M. J., Baker, B. M., Lian, J., Miura, T., Martinez-Picado, J., Addo, M. M., Walker, B. D.

    Published in Clinical infectious diseases (15-07-2010)
    “…Background. Human immunodeficiency virus (HIV) elite controllers are able to control infection with HIV-1 spontaneously to undetectable levels in the absence…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5

    Novel immunological strategies for HIV-1 eradication by Jülg, B, Barouch, DH

    Published in Journal of Virus Eradication (01-10-2015)
    “…Despite the significant advances in antiretroviral therapy (ART), HIV-1 is able to persist in cellular reservoirs. Preclinical studies suggest that the latent…”
    Get full text
    Journal Article
  6. 6

    HIV genetic diversity: any implications for drug resistance? by Jülg, B, Goebel, F D

    Published in Infection (01-08-2005)
    “…At least nine different genetic HIV-1 subtypes and several circulating recombinant forms exist, which in addition to HIV-1 subgroups and HIV-2 account for the…”
    Get full text
    Journal Article
  7. 7

    Susceptibility to HIV/AIDS: an individual characteristic we can measure? by Jülg, B, Goebel, F D

    Published in Infection (01-06-2005)
    “…Susceptibility to HIV-1 infections is, beside other factors, determined by individual host genetic variants like HLA class I alleles, CCR5 and CCR2 variants…”
    Get full text
    Journal Article
  8. 8

    Clinical news from the XVI International AIDS Conference: The attempt of a summing up by Jülg, B, Goebel, F D

    Published in Infection (01-10-2006)
    “…Topics highlighted at the XVI International AIDS Conference in Toronto included HIV/AIDS vaccine research, entry inhibitors, integrase inhibitors, new NNRTIs…”
    Get full text
    Journal Article
  9. 9

    Treatment interruption in HIV therapy: a SMART strategy? by Jülg, B, Goebel, F D

    Published in Infection (01-06-2006)
    “…Continuous HAART is standard of care for HIV-infected patients but lifelong adherence and tolerance are important concerns. Use of ART is associated with…”
    Get full text
    Journal Article
  10. 10

    What's new in HIV/AIDS? Neutralizing HIV antibodies: do they really protect? by Jülg, B, Goebel, F D

    Published in Infection (01-10-2005)
    “…Neutralizing antibodies work as a second line of defence. They are detected more or less in nearly every HIV-1-infected individual. 2G12, 2F5 and 4E10…”
    Get full text
    Journal Article
  11. 11

    What's New in HIV/AIDS? Chemokine receptor antagonists: a new era of HIV therapy? by Jülg, B, Goebel, F D

    Published in Infection (01-10-2005)
    “…Chemokine receptors are essential for human immunodeficiency virus (HIV) cell entry. CXCR4 and CCR5 are the two most relevant receptors and by inhibition of…”
    Get full text
    Journal Article
  12. 12

    Metabolic and anthropometric changes one year after switching from didanosine/stavudine to tenofovir in HIV-infected patients by Claas, G J, Jülg, B, Goebel, F D, Bogner, Johannes R

    Published in European journal of medical research (26-02-2007)
    “…Nucleoside analogues such as Didanosine and Stavudine are known to cause metabolic and body habitus changes during antiretroviral therapy. The most frequently…”
    Get more information
    Journal Article
  13. 13
  14. 14
  15. 15
  16. 16

    Infrequent recovery of HIV from, but robust exogenous infection of activated CD4+ T-cells from HIV elite controllers by Julg, B, Pereyra, F, Buzón, MJ, Piechocka-Trocha, A, Clark, MJ, Baker, BM, Lian, J, Miura, T, Martinez-Picado, J, Addo, MM, Walker, BD

    Published in Clinical infectious diseases (15-07-2010)
    “…HIV elite controllers are able to control HIV-1 infection spontaneously to undetectable levels in the absence of antiretroviral therapy, but the mechanisms…”
    Get full text
    Journal Article
  17. 17

    Hypoxic ventilatory response, ventilation, gas exchange, and fluid balance in acute mountain sickness by Bärtsch, Peter, Swenson, Erik R, Paul, André, Jülg, Bernhard, Hohenhaus, Elke

    Published in High altitude medicine & biology (2002)
    “…To examine whether sea-level hypoxic ventilatory responses (HVR) predict acute mountain sickness (AMS) and document temporal changes in ventilation, HVR, gas…”
    Get more information
    Journal Article
  18. 18

    Pulmonary manifestation of a Langerhans cell sarcoma : case report and review of the literature by JÜLG, Boris Dominik, WEIDNER, Sven, MAYR, Doris

    “…In the following, we describe the very rare case of Langerhans cell sarcoma (LCS) in the lung. Throughout the medical literature, only a few cases have been…”
    Get full text
    Journal Article
  19. 19
  20. 20